A COMPARATIVE STUDY OF POST OPERATIVE ANALGESIA AFTER SPINAL NALBUPHINE WITH BUPIVACAINE AND SPINAL BUPIVACAINE FOR LOWER LIMB SURGERIES

Dr. Dimple K. Pandya; Dr. Sangita N. Parikh; Dr. Tushar K. Patel; Dr. Mrugesh Prajapati; Dr. Jay shah

Volume : VI, Issue : IX, September - 2016

A COMPARATIVE STUDY OF POST OPERATIVE ANALGESIA AFTER SPINAL NALBUPHINE WITH BUPIVACAINE AND SPINAL BUPIVACAINE FOR LOWER LIMB SURGERIES

Dr. Dimple K. Pandya, Dr. Sangita N. Parikh, Dr. Tushar K. Patel, Dr. Mrugesh Prajapati, Dr. Jay Shah

Abstract :

AIM: The purpose of our study was to establish the effectiveness of intrathecal nalbuphine as an adjuvant and also the efficacy of nalbuphine for post–operative analgesia and its side effects if any. MATERIAL AND METHODS: 60 patients of ASA grade I and II, age group of 20–60 years, scheduled for elective lower limb surgeries were chosen for this study, patients were randomised into two equal groups of 30 each, group N (Nalbuphine group) received 3 cc of hyperbaric bupivacaine 0.5% + 0.8cc injection nalbuphine (0.8mg) intrathecally, Group B(controlled group) received 3cc of hyperbaric bupivacaine 0.5% + 0.8 cc of injection normal saline intrathecally, assessment of motor and sensory blockade was done by omage scale and pinprick method, pulse rate, B. P, respiratory rate and SPO2 were monitored. RESULTS: The difference was in significant between two groups from onset of sensory and motor blockade but mean time of post–operative analgesia in nalbuphine group –(Group–N)was highly significant than control group (Group–B), no patient developed any side effects in our study. CONCLUSION: Nalbuphine used as an adjuvant to hyperbaric bupivacaine provides better quality of blockade as compared to hyperbaric bupivacaine alone, it also prolongs the post–operative analgesia when used as an adjuvant to spinal bupivacaine in lower limb surgeries.